Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma is a research paper published in Journal of Clinical Oncology (2020). On theSindex it has a DataRank of 5.0. It has been cited 152 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.755
From this paper's citation signal
Citation Network Contribution
4.2
From 84 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
NCI NIH HHS
Grant: U10 CA180888
Intramural NIH HHS
Grant: Z99 CA999999
NCI NIH HHS
Grant: U01 CA121947
NCI NIH HHS
Grant: UG1 CA233230
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 3U10CA180888-03S1
SWOG Network Group Operations Center of the NCTN
National Institutes of Health
Grant: 3UG1CA233230-05S1
Rochester Network Lead Academic Participating Site
FWCI
12.36
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals